Dr. Behnam Ebrahimi, MD

Dr. Ebrahimi practices at Pomona Valley Hospital Medical Center in Pomona, California, part of Pomona Valley Hospital Medical Center.

Dr. Ebrahimi's NPI, 1033165139, was assigned on May 26, 2006. Dr. Ebrahimi graduated from Baylor College Of Medicine in 1997. Dr. Ebrahimi holds California license A81045.

Dr. Ebrahimi's primary practice is Pomona Valley Hospital Medical Center, at 1798 N Garey Ave, Pomona, CA 91767 in Los Angeles County. The practice phone is (909) 865-9500.

Dr. Ebrahimi's primary practice is Pomona Valley Hospital Medical Center in Pomona, California, part of Pomona Valley Hospital Medical Center. Dr. Ebrahimi is also affiliated with Casa Colina Hospital and Centers for Healthcare. The medical group on file is Inland Valley Hematology Oncology Associates. Dmand AI also links Dr. Ebrahimi to 1 more hospital, 1 physician office, 1 group practice or clinic and 1 other site, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ebrahimi practices, 6 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Ebrahimi's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Ebrahimi is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Ebrahimi's licenses on file in 2 states: California and Texas.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, lung cancer, lymphoma, multiple myeloma and neutropenia among the conditions Dr. Ebrahimi treats.

CMS data shows 1,615 Medicare services from Dr. Ebrahimi across 7 procedure codes in 2024, for 302 Medicare patients. Medicare paid $165,171 for them.

CMS counts 302 Medicare patients who saw Dr. Ebrahimi in 2024. The largest group is 65 to 74, with 124 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 2.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ebrahimi's median patient age at 67, with 59% women.

In 2024, Dr. Ebrahimi wrote 1,183 Medicare Part D claims for 170 patients. 80% of them were for generic drugs. CMS names the drug for 938 of them, across 34 drugs with 11 or more claims each, at $1,996,156 in total drug cost. In 2023, CMS named 956 claims across 33 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Ebrahimi for performance year 2024, reported individually. Dr. Ebrahimi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ebrahimi as offering telehealth.

Dmand AI links 14 papers to Dr. Ebrahimi, published from 2021 to 2025. 2021 was the busiest year, with 5. The most frequent topics are Breast Neoplasms, Cell Line, Tumor and Co-Repressor Proteins. Dr. Ebrahimi has published most often in Cancers (Basel). Dr. Ebrahimi's most frequent co-authors are Edward Robert Kost, MD, Philip T. Valente, MD and Andrew Jacob Brenner, MD, PhD.

Dmand AI links Dr. Ebrahimi to 10 clinical trials, 5 of them phase 1 studies. 4 are still active or recruiting. Conditions studied include Breast Neoplasms, Fallopian Tube Diseases and Triple Negative Breast Neoplasms. City of Hope Medical Center sponsors the most, 10.

CMS Open Payments shows 788 general payments to Dr. Ebrahimi from 54 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 74% of the total. Genentech, Inc. paid the most, $220,259.

Dmand AI lists 1 award for Dr. Ebrahimi, most recently CMS Stage 1 EHR in 2013.

Dr. Ebrahimi graduated from Baylor College Of Medicine in 1997.

Dr. Ebrahimi is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.